Latest Insider Transactions at Adial Pharmaceuticals, Inc. (ADIL)
This section provides a real-time view of insider transactions for Adial Pharmaceuticals, Inc. (ADIL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ADIAL PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ADIAL PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 29
2023
|
Kevin Schuyler Director |
BUY
Open market or private purchase
|
Direct |
700
+50.0%
|
$1,400
$2.74 P/Share
|
|
May 23
2023
|
Joseph Truluck Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
157,500
+37.27%
|
-
|
|
May 23
2023
|
William B. Stilley Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
240,800
+16.03%
|
-
|
|
May 23
2023
|
Cary J Claiborne Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
420,000
+21.65%
|
-
|
|
Dec 30
2022
|
William B. Stilley Iii Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
166,667
-14.03%
|
-
|
|
Sep 20
2022
|
Cary J Claiborne Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+6.38%
|
$0
$0.42 P/Share
|
|
Sep 19
2022
|
Cary J Claiborne Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+2.38%
|
$0
$0.43 P/Share
|
|
Aug 18
2022
|
Cary J Claiborne Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,000,000
+50.0%
|
-
|
|
Feb 23
2022
|
William B. Stilley Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+17.39%
|
-
|
|
Dec 30
2021
|
James W. Newman Jr. Director |
BUY
Open market or private purchase
|
Indirect |
15,000
+15.73%
|
$30,000
$2.72 P/Share
|
|
Dec 30
2021
|
James W. Newman Jr. Director |
BUY
Open market or private purchase
|
Direct |
10,000
+33.33%
|
$20,000
$2.66 P/Share
|
|
Dec 23
2021
|
Kevin Schuyler Director |
SELL
Bona fide gift
|
Direct |
312,990
-100.0%
|
-
|
|
Nov 30
2021
|
William B. Stilley Iii Director |
BUY
Open market or private purchase
|
Direct |
10,600
+1.12%
|
$21,200
$2.75 P/Share
|
|
Nov 29
2021
|
William B. Stilley Iii Director |
BUY
Open market or private purchase
|
Direct |
10,000
+1.07%
|
$20,000
$2.59 P/Share
|
|
Nov 26
2021
|
James W. Newman Jr. Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+22.48%
|
$20,000
$2.85 P/Share
|
|
Oct 04
2021
|
Bankole A. Johnson Director |
SELL
Open market or private sale
|
Indirect |
200,000
-57.43%
|
-
|
|
Apr 06
2021
|
Bankole A. Johnson Director |
SELL
Open market or private sale
|
Indirect |
150,000
-21.48%
|
$300,000
$2.5 P/Share
|
|
Jan 26
2021
|
James W. Newman Jr. Director |
BUY
Grant, award, or other acquisition
|
Indirect |
3,731
+4.61%
|
-
|
|
Jan 26
2021
|
William B. Stilley Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
201,109
+17.99%
|
-
|